Search

Author/Creator Brufsky, Adam M

1. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Issue 10021 (27th February 2016)

Authors:
Margolese, Richard G; Cecchini, Reena S; Julian, Thomas B; Ganz, Patricia A; Costantino, Joseph P; Vallow, Laura A; Albain, Kathy S; Whitworth, Patrick W; Cianfrocca, Mary E; Brufsky, Adam M; Gross, Howard M; Soori, Gamini S; Hopkins, Judith O; Fehrenbacher, Louis; Sturtz, Keren; Wozniak, Timothy...
Journal:
Lancet
Issue:
Volume 387:Issue 10021(2016)
Page Start:
849
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?. Issue 1 (8th May 2018)

Authors:
Landmann, Alessandra; Farrugia, Daniel J; Zhu, Li; Diego, Emilia J; Johnson, Ronald R; Soran, Atilla; Dabbs, David J; Clark, Beth Z; Puhalla, Shannon L; Jankowitz, Rachel C; Brufsky, Adam M; Ahrendt, Gretchen M; McAuliffe, Priscilla F; Bhargava, Rohit
Journal:
American journal of clinical pathology
Issue:
Volume 150:Issue 1(2018)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. Issue 9 (September 2015)

Authors:
Bear, Harry D; Tang, Gong; Rastogi, Priya; Geyer, Charles E; Liu, Qing; Robidoux, André; Baez-Diaz, Luis; Brufsky, Adam M; Mehta, Rita S; Fehrenbacher, Louis; Young, James A; Senecal, Francis M; Gaur, Rakesh; Margolese, Richard G; Adams, Paul T; Gross, Howard M; Costantino, Joseph P; Paik, Soonmy...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1037
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. Issue 9 (September 2015)

Authors:
Bear, Harry D; Tang, Gong; Rastogi, Priya; Geyer, Charles E; Liu, Qing; Robidoux, André; Baez-Diaz, Luis; Brufsky, Adam M; Mehta, Rita S; Fehrenbacher, Louis; Young, James A; Senecal, Francis M; Gaur, Rakesh; Margolese, Richard G; Adams, Paul T; Gross, Howard M; Costantino, Joseph P; Paik, Soonmy...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1037
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Issue 10021 (27th February 2016)

Authors:
Ganz, Patricia A; Cecchini, Reena S; Julian, Thomas B; Margolese, Richard G; Costantino, Joseph P; Vallow, Laura A; Albain, Kathy S; Whitworth, Patrick W; Cianfrocca, Mary E; Brufsky, Adam M; Gross, Howard M; Soori, Gamini S; Hopkins, Judith O; Fehrenbacher, Louis; Sturtz, Keren; Wozniak, Timothy...
Journal:
Lancet
Issue:
Volume 387:Issue 10021(2016)
Page Start:
857
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer. Issue 4 (22nd February 2018)

Authors:
Clark, Beth Z; Farrugia, Daniel J; Landmann, Alessandra; Diego, Emilia J; Dabbs, David J; Puhalla, Shannon L; Jankowitz, Rachel C; Brufsky, Adam M; Ahrendt, Gretchen M; McAuliffe, Priscilla F; Bhargava, Rohit
Journal:
American journal of clinical pathology
Issue:
Volume 149:Issue 4(2018)
Page Start:
332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗